Ferrous Bisglycinate for Health & Longevity

Created on 11/08/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Ferrous bisglycinate, a dietary supplement form of iron bound to the amino acid glycine, is used to refill low iron stores and correct anemia. In deficiency, it reliably does both, with less nausea and constipation than standard iron forms. In people with enough iron, the body cannot remove surplus, and genetic studies tie higher lifelong iron to a shorter life. Evidence supports it for confirmed deficiency, not general longevity use. (Full Review)

Protocol

Prevention dose
25 mg elemental iron daily
Prevented iron deficiency anemia in more than 95% of Danish pregnant women; 24 mg daily in a Thai pregnancy trial
Repletion dose
30 or 60 mg daily or on alternate days
For 56 days in blood donors with low ferritin; alternate-day and daily 30 mg performed similarly
Time of day
Morning, empty stomach
Common practice, with water or vitamin C; kept 1–2 hours from coffee, tea, dairy and calcium
Time to effect
Hemoglobin
2–8 weeks
On 60 mg daily: up 0.6 g/dL by week 2, 1.2 g/dL by week 4, 2.6 g/dL by week 8
Ferritin
Usually 2–3 months
Gains persisted 6 months after stopping in schoolchildren with low stores
Fatigue
Usually 2–3 months
Self-reported tiredness in iron-deficient adults without anemia

Benefits

Contraindications
  • People with hereditary hemochromatosis or iron overload (transferrin saturation above 45% with ferritin above 200 μg/L in premenopausal women, or 50% and 300 μg/L in men and postmenopausal women)
  • People with transfusion-dependent anemias such as thalassemia major (inferred; no human data on this form)
  • People with anemia not caused by iron deficiency, such as thalassemia trait or vitamin B12 deficiency, without documented low ferritin (inferred; no human data)
Key Interactions
  • Levothyroxine: doses separated by at least 4 hours
  • Fluoroquinolone antibiotics (ciprofloxacin, norfloxacin): antibiotic taken at least 2 hours before or 6 hours after iron
  • Tetracycline antibiotics (doxycycline, tetracycline): iron paused during the course or separated by several hours
  • Levodopa (carbidopa-levodopa): doses separated by at least 2 hours
  • Bisphosphonates (risedronate, alendronate): bisphosphonate taken while fasting, at least 30 minutes before iron
  • Integrase inhibitors (dolutegravir): dolutegravir taken 2 hours before or 6 hours after iron, or both with a meal
  • Proton pump inhibitors (omeprazole, pantoprazole): slower iron repletion; ferritin monitoring
  • Calcium supplements, calcium carbonate antacids and dairy: a 2-hour gap between iron and calcium or dairy
  • Vitamin C (additive effect): modestly better uptake, and faster loading in hemochromatosis
  • Tea and espresso coffee: no tea or espresso for 1–2 hours around the dose
  • Phytate-rich foods (whole grains, legumes): phytate blunts this form less than salts
  • Regular blood donation (other intervention): ferritin-guided dosing between donations
Theoretical (inferred from mechanism)
  • Other iron-containing supplements (multivitamins with iron, lactoferrin): total elemental iron counted across all products
  • Iron-chelating polyphenol supplements (quercetin): a 2-hour gap between doses

Risk & Side Effects

  • High: Gastrointestinal adverse events
  • Medium:
  • Low: Iron overload; reduced life expectancy; skin and soft-tissue infections; venous thromboembolism; accidental iron poisoning in young children
  • Speculative: Gut microbiome shift toward Enterobacteriaceae

Monitoring

Marker Target Why
Ferritin Above 30 μg/L (75 ng/mL or less: restless legs treatment threshold) Tracks repletion; safety check for overshoot
Transferrin saturation 20–45%; overload above 45% (premenopausal women) or 50% (men, postmenopausal women) Safety check: rising saturation stops or reduces use
Hemoglobin 12.0–15.5 g/dL (women), 13.5–17.5 g/dL (men) Rises when anemia is corrected
Mean corpuscular volume 80–100 fL Small cells normalize with repletion
Serum iron Not specified in the ER Baseline iron status
C-reactive protein Not specified in the ER Interprets ferritin
HFE genotype Not specified in the ER Identifies hereditary hemochromatosis risk

Cadence: Baseline before starting; hemoglobin at 2–4 weeks; ferritin, transferrin saturation and hemoglobin at 8–12 weeks, then every 3–6 months while supplementation continues; morning samples, at least 24 hours without iron

Qualitative Assessment

  • Energy levels and fatigue during the day
  • Exercise tolerance, such as breathlessness on stairs or training recovery
  • Restless legs symptoms and sleep continuity
  • Gastrointestinal tolerance: nausea, constipation, abdominal discomfort
  • Cold intolerance, headaches and concentration